# Dianthus Therapeutics, Inc.: Form 8-K, filed Sep 2, 2020

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2020-09-02
- Accepted by EDGAR: Sep 2, 2020, 16:05 ET
- Period: 2020-08-31
- Accession: 0001193125-20-238147
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312520238147/d937783d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312520238147/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312520238147/d937783d8k.htm

Filed Sep 2, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-238147. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.